World Health Organization. Global hepatitis report, 2017. (2017). doi:ISBN 978-92-4-156545-5
Bartenschlager, R. et al. Critical challenges and emerging opportunities in hepatitis C virus research in an
era of potent antiviral therapy: Considerations for scientists and funding agencies.
Virus Res. 248, 53–62 (2018).
Petruzziello, A., Marigliano, S., Loquercio, G., Cozzolino, A. & Cacciapuoti, C. Global
epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation
of hepatitis C virus genotypes. World J. Gastroenterol. 22, 7824–7840 (2016).
Cornberg, M. et al. A systematic review of hepatitis C virus epidemiology in Europe , Canada and Israel.
30–60 (2011). doi:10.1111/j.1478-3231.2011.02539.x
Shiferaw, F., Letebo, M. & Bane, A. Chronic viral hepatitis: policy, regulation, and
strategies for its control and elimination in Ethiopia. BMC Public Health 16, 1–13 (2016).
Mercy Jelagat Karoney, A. M. S. Hepatitis C virus ( HCV ) infection in Africa : a
review. Pan Afr. Med. J. 8688, 1–8 (2013).
J.C., E. et al. Prevalence and risk factors for hepatitis c and human immunodeficiency virus coinfection
among children in Enugu Nigeria. African J. Infect. Dis. 8, 5–8 (2014).
Semugoma, N. P. et al. Hepatitis C: A South African literature review and results from a burden of disease
study among a cohort of drug-using men who have sex with men in Cape Town, South Africa.
South African Med. J. 107, 1116 (2017).
Mutagoma, M. et al. Hepatitis C virus and HIV co-infection among pregnant women in Rwanda. BMC Infect. Dis. 17, 4–9 (2017).
Umutesi, J. et al. Prevalence of hepatitis B and C infection in persons living with HIV enrolled in
care in Rwanda. BMC Infect. Dis. 17, 1–7 (2017).
Gorar, Z. A., Butt, Z. A. & Aziz, I. Risk factors for bloodborne viral hepatitis in
healthcare workers of Pakistan: A population based case-control study. BMJ Open 4, 1–7 (2014).
Hayes, M. O. & Harkness, G. A. Body piercing as a risk factor for viral hepatitis:
an integrative research review. Am. J. Infect. Control 29, 271–274 (2001).
Mohamed, H. I. et al. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: Seroprevalence,
risk factors and related chronic liver diseases. J. Infect. Public Health 6, 186–195 (2013).
Huang, C. et al. Prevalence and risk factors of hepatitis C among former blood donors in rural China.
Int. J. Infect. Dis. 16, e731–e734 (2012).
Degenhardt, L. et al. Global prevalence of injecting drug use and sociodemographic characteristics and
prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic
review. Lancet Glob. Heal. 5, e1192–e1207 (2017).
Mbituyumuremyi, A. et al. Controlling hepatitis C in Rwanda: a framework for a national response. Bull. World Health Organ. 96, 51–58 (2018).
National Institute of Statistics of Rwanda (NISR), M. of F. and E. P. (MINECOFIN)
[Rwanda]. Rwanda Household, Integrated Survey, Living Conditions. (2015).
National Institute of Statistics of Rwanda (NISR) [Rwanda], Ministry of Health (MOH)
[Rwanda], and I. I. Rwanda Demographic and Health Survey 2014-15. (NISR, MOH,and ICF International, 2015).
Hajiani, E., Masjedizadeh, R., Hashemi, J., Azmi, M. & Rajabi, T. Hepatitis C virus
transmission and its risk factors within families of patients infected with hepatitis
C virus in southern Iran: Khuzestan. World J. Gastroenterol. 12, 7025–7028 (2006).
Zekry Farg, I., El-Dien Nouh, M. & AlFateh Mahrous, O. Intrafamilial transmission
of hepatitis C virus in Menoufia Governorate. Menoufia Medical Journal 27, 478 (2014).
Amran B. Lankarani, Maryam Ardebili, Masood Sepehrimanesh, Maryam Nejabat, M. A. &
Hemmati Rad, S. Y. H. Evaluation of hepatitis C virus intrafamilial transmission among
in Iran. Gastroenterol Hepatol Bed Bench 9, 250–258 (2016).
Omar, M. Z. et al. Role of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt.
Hepatic Med. Evid. Res. 9, 27–33 (2017).
Paez Jimenez, A. et al. HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut 59, 1554–1560 (2010).
Bi-fen Luo, Hui-ying Rao, Y. G. and L. W. Risk factors for familial clustering of
hepatitis C virus infection in a Chinese Han population: a cross-sectional study.
BMC Public Health 18, 708 (2018).
Rwanda Ministry of Health, W. H. O. Rwanda Non-communicable Diseases Risk Factors Report. WHO (2015).
Latt, N., Alachkar, N. & Gurakar, A. Hepatitis C virus and its renal manifestations:
A review and update. Gastroenterol. Hepatol. 8, 434–445 (2012).